NMN: What the Research Actually Shows

By Longevity Lab · Published: July 21, 2026

Based on peer-reviewed research — full source list at the end of this article. This is educational information, not medical advice.

What NMN is, and where NAD+ comes in

Here is what the research on NMN actually shows: nicotinamide mononucleotide (NMN) does raise NAD+ levels in human blood, but it has not been shown to slow aging or extend healthy life in people. The encouraging findings come mostly from mice, while human trials are small, short and mixed. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in producing energy inside cells and in the enzymes tied to DNA repair and the regulation of aging (Sirtuins). NAD+ levels in tissue decline with age, so the idea is simple: top it back up with a precursor. NMN is one of those precursors.

What animal experiments with NMN found

In mice, long-term NMN supplementation improved insulin sensitivity, metabolism, endurance and a range of age-related measures. Those studies, including work from the Sinclair and Imai groups, are what set off the excitement. But rodents are not people: doses, metabolism and lifespan are not comparable, and many of the rejuvenating effects seen in mice do not reproduce in humans. In people, the metabolic half of that picture is easier to measure than to supplement blindly: insulin resistance can be estimated from an ordinary blood panel with the METS-IR: metabolic score for insulin resistance.

What is known about taking NMN in humans

Human research is still thin, and the trials that exist are small and short, running weeks to months. Here is what they show.

• NMN consistently raises NAD+ levels in the blood, so it does reach its target.
• Individual RCTs reported improvements in insulin sensitivity (for example, in women with Prediabetes) and in some physical measures, including aerobic endurance, grip strength and walking.
• The results are inconsistent: not every trial finds a clinically meaningful benefit, and the effects that do appear are usually modest.

The key point: a higher NAD+ level is a Biomarker of aging, not proof of slower aging. There is no evidence yet that NMN extends healthy life in humans. If you want a measure that tracks aging itself rather than one molecule in the blood, the available approaches are compared in Biological age tests: what to measure and how to choose a method.

NMN safety and regulatory status

In short-term trials NMN was generally well tolerated, and serious side effects were rare. Long-term safety has not been studied, product quality on the market varies, and the regulatory status keeps shifting from country to country. This is a supplement, not a drug: it does not go through the same review of efficacy.

Longevity Lab does not sell supplements and does not advise on taking them. Make any supplement decision together with your doctor, especially if you have a chronic condition or take medication.

Should you take NMN

The honest answer: the evidence is not strong enough for a confident yes. Following the field because it interests you is reasonable. If the goal is to actually affect aging, the money and effort go further on movement, sleep and nutrition, where the evidence is an order of magnitude stronger, and that is precisely the ground covered in Longevity — the science of aging more slowly.

Frequently asked questions

Sources

Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.